The Protective Effect of Egb 761 Against 3-Nitropropionic Acid-Induced Hearing Loss: The Role of Sirtuin 1
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Objectives. Local administration of 3-nitropropionic acid (3-NP) to the inner ear induces sensorineural hearing loss. Several studies have shown the otoprotective effects of ginkgo biloba extract EGb 761. Moreover, EGb 761 has been reported to activate Sirtuin 1 (SIRT1). The present study was designed to investigate whether EGb 761 prevents 3-NP-induced sensorineural hearing loss and determine its effects on the expression of SIRT1. Methods. Sprague Dawley rats were divided into four experimental groups: control group receiving vehicle of 3-NP, EGb group receiving EGb 761, 3-NP group receiving 3-NP, and EGb+3-NP group receiving EGb 761 and 3-NP. EGb 761 was given orally for 5 days. The 3-NP solution was injected into the tympanum 3 days after the start of EGb 761 administration. The auditory brainstem response was recorded before and after the injection. At 4 weeks after the administration of 3-NP or vehicle of 3-NP, cochleae were harvested, and hematoxylin and eosin staining and immunohistochemistry for SIRT1 antibody were performed. Results: EGb+3-NP group showed significantly lower threshold shifts than 3-NP group. There was a significant preservation of type II fibrocytes and spiral ganglion cells in EGb+3-NP group than in 3-NP group. In EGb+3-NP group, there was a significantly greater number of SIRT1 immunopositive type II fibrocytes and spiral ganglion cells than in 3-NP group. Calculating the percentage of SIRT1 immunoreactive type II fibrocytes and spiral ganglion cells in viable type II fibrocytes and spiral ganglion cells, respectively, EGb+3-NP group showed significantly higher SIRT1 immunoreactive cells than 3-NP group. Conclusion. These results suggest that EGb 761 may prevent hearing loss induced by 3-NP in an acute ototoxic animal model, which appears to be related with SIRT1 expression.
Abstract
Objectives. Local administration of 3-nitropropionic acid (3-NP) to the inner ear induces sensorineural hearing loss. Several studies have shown the otoprotective effects of ginkgo biloba extract EGb 761. Moreover, EGb 761 has been reported to activate Sirtuin 1 (SIRT1). The present study was designed to investigate whether EGb 761 prevents 3-NP-induced sensorineural hearing loss and determine its effects on the expression of SIRT1. Methods. Sprague Dawley rats were divided into four experimental groups: control group receiving vehicle of 3-NP, EGb group receiving EGb 761, 3-NP group receiving 3-NP, and EGb+3-NP group receiving EGb 761 and 3-NP. EGb 761 was given orally for 5 days. The 3-NP solution was injected into the tympanum 3 days after the start of EGb 761 administration. The auditory brainstem response was recorded before and after the injection. At 4 weeks after the administration of 3-NP or vehicle of 3-NP, cochleae were harvested, and hematoxylin and eosin staining and immunohistochemistry for SIRT1 antibody were performed. Results: EGb+3-NP group showed significantly lower threshold shifts than 3-NP group. There was a significant preservation of type II fibrocytes and spiral ganglion cells in EGb+3-NP group than in 3-NP group. In EGb+3-NP group, there was a significantly greater number of SIRT1 immunopositive type II fibrocytes and spiral ganglion cells than in 3-NP group. Calculating the percentage of SIRT1 immunoreactive type II fibrocytes and spiral ganglion cells in viable type II fibrocytes and spiral ganglion cells, respectively, EGb+3-NP group showed significantly higher SIRT1 immunoreactive cells than 3-NP group. Conclusion. These results suggest that EGb 761 may prevent hearing loss induced by 3-NP in an acute ototoxic animal model, which appears to be related with SIRT1 expression.
참고문헌 (29)
- Sone M, "Upregulation of HSP by geranylgeranylacetone protects the cochlear lateral wall from endotoxin-induced inflammation", Hear Res, 204(1-2), pp.140~146 (2005)[DOI]
- Yin HY, "Protective effect of geranylgeranylacetone on cisplatin ototoxicity", Chemotherapy, 55(1), pp.1~5 (2009)[DOI]
- Brouillet E, "The 3-NP model of striatal neurodegeneration", Curr Protoc Neurosci, 67, pp.9~ (2014)
- Khan A, "Neuroprotective effect of hemeoxygenase-1", glycogen synthase kinase-<TEX>$3{\beta}$<, Neuroscience, pp.2015, 287[DOI]
- Kumar P, "Role of neurosteroids in experimental 3-nitropropionic acid induced neurotoxicity in rats", Eur J Pharmacol, 723, pp.38~45 (2014)[DOI]
- Drew PD, "Inhibition of microglial cell activation by cortisol", Brain Res Bull, 52(5), pp.391~396 (2000)[DOI]
- Longpre F, "Protection by EGb 761 against beta-amyloid-induced neurotoxicity: involvement of NF-kappaB, SIRT1, and MAPKs pathways and inhibition of amyloid fibril formation", Free Radic Biol Med, 41(12), pp.1781~1794 (2006)[DOI]
- Beal MF, "Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid", J Neurosci, 13(10), pp.4181~4192 (1993)[DOI]
- Hoya N, "A novel animal model of acute cochlear mitochondrial dysfunction", Neuroreport, 15(10), pp.1597~1600 (2004)[DOI]
- Fujinami Y, "Enhanced expression of C", EBP homologous protein (CHOP) precedes degeneration of fibrocytes in the lateral wall after acute cochlear mitochondrial dysfunction induced by 3-nitropropionic acid, 2010, pp.56(3), 487~494
- Fujioka M, "Pharmacological inhibition of cochlear mitochondrial respiratory chain induces secondary inflammation in the lateral wall: a potential therapeutic target for sensorineural hearing loss", PLoS One, 9(3), pp.e90089~ (2014)[DOI]
- Koo JW, "The efficacy and safety of systemic injection of Ginkgo biloba extract, EGb761, in idiopathic sudden sensorineural hearing loss: a randomized placebo-controlled clinical trial", Eur Arch Otorhinolaryngol, 273(9), pp.2433~2441 (2016)[DOI]
- Tziridis K, "Protective effects of Ginkgo biloba extract EGb 761 against noise trauma-induced hearing loss and tinnitus development", Neural Plast, 2014, pp.427298~ (2014)
- Donmez G, "The neurobiology of sirtuins and their role in neurodegeneration", Trends Pharmacol Sci, 33(9), pp.494~501 (2012)[DOI]
- Yamakuchi M, "MiR-34, SIRT1 and p53: the feedback loop", Cell Cycle, 8(5), pp.712~715 (2009)[DOI]
- Yeung F, "Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase", EMBO J, 23(12), pp.2369~2380 (2004)[DOI]
- Xiong H, "SIRT1 expression in the cochlea and auditory cortex of a mouse model of age-related hearing loss", Exp Gerontol, 51, pp.8~14 (2014)[DOI]
- Tian C, "Korean red ginseng ameliorates acute 3-nitropropionic acid-induced cochlear damage in mice", Neurotoxicology, 34, pp.42~50 (2013)[DOI]
- Hequembourg S, "Spiral ligament pathology: a major aspect of age-related cochlear degeneration in C57BL", 6 mice, 2001, pp.2(2), 118~129
- Wang Y, "Dynamics of noise-induced cellular injury and repair in the mouse cochlea", J Assoc Res Otolaryngol, 3(3), pp.248~268 (2002)[DOI]
- Agarwal L, "Vasodilators and vasoactive substances for idiopathic sudden sensorineural hearing loss", Cochrane Database Syst Rev, (4) (2009)
- Birks J, "Ginkgo biloba for cognitive impairment and dementia", Cochrane Database Syst Rev, (1) (2009)
- Eckert A, "Stabilization of mitochondrial membrane potential and improvement of neuronal energy metabolism by Ginkgo biloba extract EGb 761", Ann N Y Acad Sci, 1056, pp.474~485 (2005)[DOI]
- Mahdy HM, "The effect of Ginkgo biloba extract on 3-nitropropionic acid-induced neurotoxicity in rats", Neurochem Int, 59(6), pp.770~778 (2011)[DOI]
- Nevado J, "Ginkgo biloba extract (EGb761) protects against aging-related caspase-mediated apoptosis in rat cochlea", Acta Otolaryngol, 130(10), pp.1101~1112 (2010)[DOI]
- Park SY, "Renexin as a rescue regimen for noise-induced hearing loss", Noise Health, 16(72), pp.257~264 (2014)[DOI]
- Xu O, "Effect of combination of Ginkgo leaf extract and deferoxamine in preventing and treating ototoxicity of cisplatin", Zhongguo Zhong Xi Yi Jie He Za Zhi, 24(10), pp.915~918 (2004)
- Xiong H, "Activation of miR-34a", SIRT1, Neurobiol Aging, pp.2015, 36(4)[DOI]
- Revollo JR, "The ways and means that fine tune Sirt1 activity", Trends Biochem Sci, 38(3), pp.160~167 (2013)[DOI]